Plasma accelerator
US-11013100-B2 · May 18, 2021 · US
US11426609B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11426609-B2 |
| Application number | US-202117171220-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 9, 2021 |
| Priority date | Apr 16, 2010 |
| Publication date | Aug 30, 2022 |
| Grant date | Aug 30, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention comprises a method and apparatus for treating a tumor of a patient with charged particles, comprising the step of developing a multi-modality treatment plan, the multi-modality treatment plan directing: (1) use of a first beam type to treat a first volume of the tumor, the first beam type a first mass per particle and (2) use of a second beam type to treat a second volume of the tumor, the second beam type comprising a second mass per particle, where the second mass per particle is at least ten percent different than the first mass per particle and the second volume differs from the first volume. The multi-modality treatment plan is optionally formed by selectively merging treatment plans using the respective particle types or is developed using properties of the multiple particle types.
Opening claim text (preview).
The invention claimed is: 1. An apparatus for treating a tumor of a patient with charged particles, comprising: a cancer therapy system, comprising: an accelerator configured to accelerate both a first particle and a second particle, said first particle comprising a first mass per particle and a second particle comprising a second mass per particle, the second mass per particle at least ten percent greater than the first mass per particle, said accelerator further comprising: a synchrotron, said synchrotron configured to: accelerate the first particle at a first time to treat a first mean depth of the tumor, the first particle comprising a negatively charged particle, said negatively charged particle comprising an electron; and accelerate, after reversing polarity of a bending magnet of said synchrotron, the second particle at a second time to treat a second mean depth of the tumor, the second particle comprising a positively charged particle; and a beam transport system configured to deliver, from said accelerator, the first particle and the second particle at least into a patient position. 2. An apparatus for treating a tumor of a patient with charged particles, comprising: a cancer therapy system, comprising: an accelerator configured to accelerate both a first particle and a second particle, said first particle comprising a first mass per particle and said second particle comprising a second mass per particle, the second mass per particle at least ten percent greater than the first mass per particle, said accelerator further comprising: a synchrotron, the first particle comprising two or fewer protons per nucleus, the second particle comprising six or more protons per nucleus; and an extraction foil, wherein the first particle passes through said extraction foil and exits said accelerator with less energy than prior to striking said extraction foil; and a beam transport system configured to deliver, from said accelerator, the first particle and the second particle at least into a patient position.
Ions; Protons · CPC title
Beam delivery systems · CPC title
using functional images, e.g. PET or MRI · CPC title
using an active marker · CPC title
Transmission computed tomography [CT] · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.